 |
 |
|
|
RESÚMENES MAYO 2007 |
Psychotic Disorders & Antipsychotics
(Haga un click en la información del journal para acceder
al resúmen)
Elevated hemoglobin A1c as a possible
indicator of diabetes mellitus and diabetic ketoacidosis
in schizophrenia patients receiving atypical antipsychotics
Henderson
DC, Cagliero E, Copeland PM, Louie PM, Borba CP, Fan X, Freudenreich O, Goff DC
J Clin
Psychiatry. 2007 Apr;68(4):533-41
Quetiapine and long-term weight change: a
comprehensive data review of patients with schizophrenia
Brecher M, Leong RW, Stening G, Osterling-Koskinen L, Jones AM
J Clin
Psychiatry. 2007 Apr;68(4):597-603
De novo emergence of obsessive-compulsive
symptoms with atypical antipsychotics in asian patients with schizophrenia
or schizoaffective disorder: a retrospective, cross-sectional study
Mahendran R, Liew E, Subramaniam M
J Clin
Psychiatry. 2007 Apr;68(4):542-5
Differentiation in the Preonset Phases of Schizophrenia and Mood Disorders:
Evidence in Support of a Bipolar Mania Prodrome
Schizophrenia
Bulletin 2007 33(3):703-714
Antibodies to Toxoplasma gondii in
Patients With Schizophrenia: A Meta-Analysis
E.
Fuller Torrey, John J. Bartko,
Zhao-Rong Lun and Robert H.
Yolken
Schizophrenia
Bulletin 2007 33(3):729-736
Predictive Validity of
Proposed Remission Criteria in First-Episode Schizophrenic Patients Responding
to Antipsychotics
Lex
Wunderink, Fokko J. Nienhuis, Sjoerd Sytema and Durk Wiersma
Schizophrenia
Bulletin 2007 33(3):792-796
Chinese
herbal medicine for schizophrenia. Cochrane systematic review of
randomised trials
John
Rathbone, Lan
Zhang, Mingming Zhang, Jun Xia,
Xiehe Liu, Yanchun Yang,
Clive E. Adams
The British Journal of Psychiatry (2007) 190:
379-384
Clinical pharmacokinetics of atypical antipsychotics :
a critical review of the relationship between plasma concentrations and
clinical response
Mauri MC,
Volonteri LS, Colasanti A, Fiorentini A, De Gaspari IF, Bareggi SR
Clin Pharmacokinet. 2007;46(5):359-88
Rapidly disintegrating risperidone
in subjects with schizophrenia or schizoaffective disorder: A summary of ten
phase I clinical trials assessing taste, tablet disintegration time,
bioequivalence, and tolerability
Thyssen A, Remmerie B, D'Hoore P, Kushner S, Mannaert E
Clin Ther. 2007 Feb;29(2):290-304
Pharmacokinetics
of Aripiprazole and Concomitant Carbamazepine
Citrome, Leslie; Macher,
Jean-Paul; Salazar, Daniel E; Mallikaarjun, Suresh; Boulton, David W
Journal of Clinical
Psychopharmacology. 27(3):279-283,
June 2007
All-Cause
Treatment Discontinuation in Schizophrenia During
Treatment With Olanzapine Relative to Other Antipsychotics: An Integrated Analysis
Beasley, Charles M. Jr;
Stauffer, Virginia L; Liu-Seifert, Hong; Taylor, Cindy C.; Dunayevich,
Eduardo; Davis, John M
Journal of Clinical
Psychopharmacology. 27(3):252-258,
June 2007
The Effectiveness
of Intramuscular Biperiden in Acute Akathisia: A Double-Blind, Randomized, Placebo-Controlled
Study
Baskak, Bora; Atbasoglu, E. Cem; Ozguven, Halise Devrimci; Saka, Meram Can; Gogus, Ali Kemal
Journal of Clinical
Psychopharmacology. 27(3):289-294,
June 2007
Aripiprazole effects in patients with acute
schizophrenia experiencing higher or lower agitation: a post hoc analysis of 4
randomized, placebo-controlled clinical trials
Marder SR,
West B, Lau GS, Pultz JA, Pikalov A, Marcus RN, Gutierrez-Esteinou
R, Crandall DT
J Clin Psychiatry. 2007 May;68(5):662-8
Prolactin serum levels in
paranoid versus nonparanoid male schizophrenia
patients treated with risperidone
Segal, Michael; Avital, Avi; Derevenski, Andrei; Berstein, Severina; Sandbank,
Sergio; Weizman, Abraham
International
Clinical Psychopharmacology. 22(4):192-196, July 2007
Similar frequency
of abnormal correlation between serum leptin levels
and BMI before and after olanzapine treatment in
schizophrenia
Baptista,
Trino; Davila, Adriana; El Fakih, Yamily; Uzcategui, Euderruh; Rangel, Nairy N;
Olivares, Yamile; Galeazzi, Tatiana; Vargas, Doritza; Pena, Rocio; Marquina,
David; Villarroel, Vanesa; Teneud, Luis; Beaulieu, Serge
International Clinical Psychopharmacology.
22(4):205-211, July 2007
Factors
associated with antipsychotic dosing in psychiatric inpatients: a prospective
study
Barbui,
Corrado; Biancosino, Bruno; Esposito, Eleonora; Marmai, Luciana; Dona, Silvia;
Grassi, Luigi
International Clinical Psychopharmacology.
22(4):221-225, July 2007
Prevalence and
nature of side effects during clozapine maintenance
treatment and the relationship with clozapine dose
and plasma concentration
Yusufi, Babur; Mukherjee, Sujoy; Flanagan,
Robert; Paton, Carol; Dunn, Graham; Page, Eleanor;
Barnes, Thomas R.E
International Clinical Psychopharmacology.
22(4):238-243, July 2007
Cycloid Psychosis: An Examination of the
Validity of the Concept
Victor Peralta, Manuel J. Cuesta, and Maria Zandio
Current Psychiatry Reports
2007, 9:184-192
Folie à Deux and Shared Psychotic Disorder
Mitsue Shimizu, Yasutaka Kubota, Motomi Toichi, and Hisamitsu Baba
Current Psychiatry Reports
2007, 9:200-205
Is the Schizophrenia Diagnosis Still
Appropriate?
Heinz Häfner
Psychiat Prax
2007; 34: 175-180
The
schizophrenias, the neuroses and the covered wagon; a critical review
|
Neuropsychiatric Disease and Treatment. Volume: 3 | Issue: 1: 133-143
Efficacy and
Safety of Oral Aripiprazole Compared with Haloperidol
in Patients Transitioning from Acute Treatment with Intramuscular Formulations
DANIEL, DAVID G; CURRIER, GLENN W; ZIMBROFF, DAN L;
ALLEN, MICHAEL H; OREN, DAN; MANOS, GEORGE; MCQUADE, ROBERT; PIKALOV, ANDREI A.
III; CRANDALL, DAVID T
Journal
of Psychiatric Practice. 13(3):170-177, May 2007
Early Prediction Of Antipsychotic NonResponse Among
Patients With Schizophrenia
Leucht S et al.
J Clin Psychiatry 2007;
68:352-360
TEXTO GRATUITO
Quetiapine
demonstrates good tolerability and is associated with improvements in extrapyramidal symptoms in patients with schizophrenia
switched from other antipsychotics: results of a
naturalistic study
Jonathan S. E. Hellewell
International
Journal of Psychiatry in Clinical Practice, Volume 11, Issue 2 2007 , pages 112 - 122
Metabolic differences between Asian and
Caucasian patients on clozapine treatment
Mythily Subramaniam, Chee
Ng, Siow-Ann Chong, Rathi Mahendran, Tim Lambert,
Elaine Pek, Chan Yiong Huak
Human
Psychopharmacology: Clinical and Experimental. Volume 22,
Issue 4, Pages 217 - 222
Attenuating
effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind
placebo-controlled study
Michael Poyurovsky, Camil Fuchs, Artashez Pashinian, Aya Levi, Sarit Faragian, Rachel Maayan and Irit Gil-Ad
Psychopharmacology. Volume 192, Number 3 / June, 2007: 441-448
Long-acting
risperidone injection: efficacy, safety, and
cost-effectiveness of the first long-acting atypical antipsychotic
Neuropsychiatric Disease
and Treatment. Volume:
3 | Issue:
1: 13-39
One-year follow-up of patients
with first-episode schizophrenia (comparison between remitters and
non-remitters)
| | |
Neuropsychiatric Disease and Treatment. Volume: 3 | Issue: 1: 153-160
Oral fluphenazine
versus placebo for schizophrenia: a Cochrane systematic review of 40 years of randomised controlled trials
Hosam El-Din
Matar, Muhammad Qutayba Almerie, Ana María Giraldo, Clive E. Adams
Rev Col Psiquiatria. Año
43 Volumen XXXVI Número 1 Marzo 2007:8-17
TEXTO GRATUITO
Epidemiologic studies about association of
mental disorders and metabolic syndrome
TEIXEIRA, Paulo José Ribeiro
and ROCHA, Fábio Lopes
Rev. psiquiatr. clín., 2007, vol.34, no.1, p.28-38
TEXTO GRATUITO
Efficacy of flupentixol and risperidone in
chronic schizophrenia with predominantly negative symptoms
Stephan Ruhrmann, Werner Kissling,
Otto-Michael Lesch, Max Schmauss,
Ute Seemann and Michael Philipp
High clozapine
concentrations in leukocytes in a patient who developed leukocytopenia
Niels Bergemann, Fatima Abu-Tair, Rolf Aderjan and Jürgen Kopitz
Characteristics and clinical
correlates of restless legs syndrome in schizophrenia
Seung-Gul Kang, Heon-Jeong Lee, Sung Won Jung, Sung
Gender-specific associations
of depression with positive and negative symptoms in acute schizophrenia
Matthias J. Müller
Effects of antipsychotics
on cognitive performance in drug-naive schizophrenic patients
Shin-Min Lee,
Yuan-Hwa Chou, Min-Hui Li,
Fang-Jung Wan and Mao-Hsiung Yen
Comparison of Clozapine-Amisulpride
and Clozapine-Quetiapine Combinations for Patients With Schizophrenia Who Are Partially Responsive to Clozapine: A Single-Blind Randomized Study
Yasin Genç, Ender Taner,
Selcuk Candansayar
Adv Ther. Volume 24 No. 1
January/February 2007 Pgs. 1-13
Appropriate Intervention Strategies for
Weight Gain Induced by Olanzapine: A Randomized Controlled
Study
W. Milano, F.
Grillo, A. Del Mastro, M. De Rosa, B. Sanseverino, C. Petrella, A. Capasso
Adv Ther. Volume 24 No. 1
January/February 2007 Pgs. 123-134